Inogen (INGN) Return on Capital Employed (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -119.00 |
| Dec 31, 2025 | 58.00 |
| Sep 30, 2025 | 36.00 |
| Jun 30, 2025 | 76.00 |
| Mar 31, 2025 | 463.00 |
| Dec 31, 2024 | 662.00 |
| Sep 30, 2024 | 1,569.00 |
| Jun 30, 2024 | 75.00 |
| Mar 31, 2024 | -33.00 |
| Dec 31, 2023 | 483.00 |
| Sep 30, 2023 | -1,455.00 |
| Jun 30, 2023 | -377.00 |
| Mar 31, 2023 | -527.00 |
| Dec 31, 2022 | -1,464.00 |
| Sep 30, 2022 | -421.00 |
| Jun 30, 2022 | -353.00 |
| Mar 31, 2022 | -263.00 |
| Dec 31, 2021 | -23.00 |
| Sep 30, 2021 | 185.00 |
| Jun 30, 2021 | 338.00 |
| Mar 31, 2021 | 8.00 |
| Mar 31, 2020 | -179.00 |
| Dec 31, 2019 | -299.00 |
| Sep 30, 2019 | -122.00 |
| Jun 30, 2019 | -86.00 |
| Mar 31, 2019 | -178.00 |
| Dec 31, 2018 | -98.00 |
| Sep 30, 2018 | -65.00 |
| Jun 30, 2018 | 117.00 |
| Mar 31, 2018 | 73.00 |
| Dec 31, 2017 | -113.00 |
| Sep 30, 2017 | 32.00 |
| Jun 30, 2017 | -50.00 |
| Mar 31, 2017 | 82.00 |
| Dec 31, 2016 | 47.00 |
| Sep 30, 2016 | 11.00 |
| Jun 30, 2016 | 71.00 |
| Mar 31, 2016 | -20.00 |
| Dec 31, 2015 | 128.00 |
| Sep 30, 2015 | -40.00 |
| Jun 30, 2015 | 65.00 |
| Mar 31, 2015 | 65.00 |
| Dec 31, 2014 | 80.00 |
| Sep 30, 2014 | 188.00 |
| Jun 30, 2014 | -9.00 |